SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

22 Jul 2022 Evaluate
The Sales for the quarter ended June 2022 of Rs. 123.66 millions rose by 25.02% from Rs. 98.91 millions.A humble growth in net profit of 7.87% reported in the quarter ended June 2022 to Rs. 37.71  millions from Rs. 34.96 millions.Operating profit for the quarter ended June 2022 rose to 71.37 millions as compared to 56.84 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 123.66 98.91 25.02 123.66 98.91 25.02 365.65 224.45 62.91
Other Income 0.48 0.70 -31.43 0.48 0.70 -31.43 6.29 4.08 54.17
PBIDT 71.37 56.84 25.56 71.37 56.84 25.56 180.90 67.89 166.46
Interest 1.12 4.64 -75.86 1.12 4.64 -75.86 12.15 15.48 -21.51
PBDT 70.25 52.20 34.58 70.25 52.20 34.58 168.75 52.41 221.98
Depreciation 17.86 17.24 3.60 17.86 17.24 3.60 69.74 64.56 8.02
PBT 52.39 34.96 49.86 52.39 34.96 49.86 99.01 -12.15 -914.90
TAX 14.68 0.00 0.00 14.68 0.00 0.00 -122.75 0.00 0.00
Deferred Tax 14.68 0.00 0.00 14.68 0.00 0.00 -122.75 0.00 0.00
PAT 37.71 34.96 7.87 37.71 34.96 7.87 221.76 -12.15 -1925.19
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 57.71 57.47 0.43 57.71 57.47 0.43 49.47 30.25 63.56

Zenotech Laboratorie Share Price

49.37 1.34 (2.79%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×